ASPG and acute lymphoblastic leukemia: Compared with E. coli-asparaginase, PEG-asparaginase produces prolonged depletion of asparagine and is associated with reduced incidence of certain toxicities (i.e., hypersensitivity reactions), thereby making it preferable for use in ALL treatment19, 20, 21.